Tata Elaxi Q2 FY25 Earnings Conference Call Summary
Key Participants:
- Manoj Raghavan, Managing Director & CEO
- Nitin Pai, Chief Marketing and Chief Strategy Officer
- Gaurav Bajaj, Chief Financial Officer
Opening Remarks: Tribute to Mr. Ratan Tata
- Mr. Manoj Raghavan opened the call by paying respects to Mr. Ratan Tata, acknowledging his legacy and contributions to the company’s foundation.
Financial Performance
- Revenue from Operations: INR 955.1 crores, a 3.1% QoQ growth.
- Constant Currency Growth: 0.2% QoQ.
- EBITDA Margins: Expanded by 70 bps to 27.9%.
- PAT (Profit After Tax): Increased by 24.6% QoQ, reaching INR 229.4 crores.
- R&D Incentives and Tax Credits: Helped bolster bottom-line performance.
Business Segment Performance
Transportation
- Growth: 4.4% QoQ in constant currency, established as the primary growth driver.
- Key Factors: Strong capabilities in ADAS, connected vehicles, electric vehicles, and software-defined vehicles (SDV).
- Major Deals:
- $50 million deal with European OEM: Multi-year engagement for SDV platform development and next-gen mobility solutions.
- Strategic Partnership with Nidec Corporation, Japan: Supporting automotive technology initiatives.
- Global Innovation Center in Bangalore: Collaboration with Emerson for next-gen mobility solutions.
Media and Communication
- Performance: 2.2% QoQ decline in constant currency.
- Reasons: Delayed customer decisions, project completions, and budget constraints.
- Notable Milestones:
- World's First RDK Broadband Implementation for Qualcomm: Enabling 5G broadband services for telecom operators.
- AI Center of Excellence Deal: With a Middle East operator to drive transformation.
Healthcare and Life Sciences
- Performance: 11.2% QoQ decline in constant currency.
- Reasons: Delays in renewals and program launches with a major US-based client.
- Recovery Outlook: Partial recovery expected in Q3, full recovery in Q4.
- Key Developments:
- New Clients: Global renal care leader and US-based healthtech AI company.
- Partnership with Skanray: Developing surgical imaging core technology and software.
- Robotics Innovation Lab in Frankfurt: Partnership with Denso Robotics and AATech for automation and robotics across sectors.
Geographic Performance
- India: Revenue grew 31.2% YoY.
- Japan and Emerging Markets: Robust growth of 81.9% YoY.
People and Hiring
- Attrition: Maintained at 12.5%.
- Hiring Plans: Fresher hiring postponed to Q3 and Q4 FY25.
Management Outlook and Guidance
- Growth Expectation: Healthy deal pipeline for Q3, continued growth in transportation vertical, and recovery in healthcare and media segments.
- Double-digit Growth Target for FY25: Although challenging, Mr. Raghavan remains optimistic due to strong deal wins and a robust pipeline.
Analyst Q&A Highlights
Transportation Segment
- Sustainability of Growth:
- Analysts expressed concerns about the industry-wide softness and EV target pullbacks.
- Mr. Raghavan remained confident in the growth trajectory due to secured deals, ramp-ups, and pipeline strength.
- SDV Deal in Asia:
- Substantial ramp-up already achieved; further progress expected in the next two quarters.
Healthcare and Life Sciences Segment
- Revenue Decline:
- The drop was due to program delays, not customer loss.
- A recovery is expected by Q4 FY25 with program restarts in Q3.
Media and Communication Segment
- Demand Trends:
- Mr. Raghavan described the environment as a "bloodbath" due to budget tightening and consolidation.
- The company is focusing on leveraging IPs to help customers with cost reduction.
- RDK Broadband Opportunity:
- Positioned as a long-term strategic initiative with significant adoption anticipated over the next two years.
Headcount Management
- Hiring Strategy:
- Focused on managing existing resources effectively, maintaining a healthy bench and utilization rate. Fresher hiring will occur in Q3 and Q4.
Margins
- Margin Outlook:
- Despite salary increases in Q2, margins are expected to improve in H2 FY25.
JLR (Jaguar Land Rover)
- Growth and Contribution:
- Continued growth anticipated but at a slower rate than other OEMs.
- Recent approval for higher transaction limits does not guarantee INR 1,000 crore revenue in FY25.
FY25 Growth Target
- Feasibility:
- The goal of double-digit growth remains, despite market challenges, backed by the secured deals and pipeline.
New Verticals and M&A
- Exploration of New Sectors:
- Tata Elaxi is actively evaluating options for new verticals, with announcements likely in the next fiscal year.
Defense and Semiconductor Opportunities
- Defense Sector:
- Tata Elaxi is involved in defense electronics via DRDO and ISRO partnerships and has strong capabilities in imaging, hardware design, and wireless technologies.
- Semiconductor Sector:
- Exploring chip design opportunities, which are highly complex but promising for the future.
Conclusion
- Tata Elaxi remains optimistic about H2 FY25 with a strong focus on transportation growth, expected recovery in healthcare, cautious optimism for media, and strategic initiatives in new verticals. Margins are anticipated to improve, and the company is well-positioned to meet its FY25 growth targets despite industry challenges.
Note: We are not SEBI registered; this is not a buy or sell recommendation.

Comments
Post a Comment